secwatch.observer — SEC 8-K summary
======================================

Issuer:     BAXTER INTERNATIONAL INC (BAX)
CIK:        0000010456
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001628280-25-021320
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Baxter Q1 beats: sales $2.63B, adj. EPS $0.55; FY guidance raised to $2.47-$2.55
--------------------------------------------------------------------------------

- First-quarter sales $2.63B, up 5% reported and operational, exceeding guidance.
- GAAP diluted EPS from continuing ops $0.13; adjusted diluted EPS $0.55, both above guidance.
- Full-year 2025 adjusted EPS guidance raised: lower end increased to $2.47-$2.55 range.
- Chair and interim CEO Brent Shafer cites transformation progress and focus on essential medtech.
- Management notes global macroeconomic uncertainty but remains confident in trajectory.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10456/000162828025021320/0001628280-25-021320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10456/000162828025021320/bax-20250501.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-021320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer